H.Con.Res. 42 · 117th Congress
Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
- Stage
- In committee
- Sponsor
- David McKinley
- Introduced
- 2021-07-21
- Latest action
- 2021-07-22 · Referred to the Subcommittee on Health.
Subjects
Health
Civil actions and liability
State and local government operations
Solid waste and recycling
State and local finance
Consumer affairs
Prescription drugs
Drug trafficking and controlled substances
Transportation costs